Email this article Mobile application “Aterostop” for a comprehensive assessment of cardiovascular risk in patients in the Russian population
- Authors: Sergienko I.V.1, Ansheles A.A.1, Boytsov S.A.1
-
Affiliations:
- National Medical Research Center of Cardiology
- Issue: Vol 93, No 4 (2021)
- Pages: 415-420
- Section: Original articles
- URL: https://journals.rcsi.science/0040-3660/article/view/71209
- DOI: https://doi.org/10.26442/00403660.2021.04.200683
- ID: 71209
Cite item
Full Text
Abstract
The article provides an overview of an innovative software product for a comprehensive assessment of cardiovascular risk in cardiac patients in the Russian Federation. Based on the new recommendations of the Russian National Atherosclerosis Society (2020), the Aterostop application allows to assess cardiovascular risk, determine the patient’s achievement of target levels of low-density lipoprotein cholesterol, and also provides recommendations for correcting lipid-lowering therapy. The calculator is implemented as a web browser version, as well as a mobile application for Android and iOS platforms.
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
Igor V. Sergienko
National Medical Research Center of Cardiology
Email: a.ansheles@gmail.com
ORCID iD: 0000-0003-1534-3965
д.м.н., руководитель лаб. фенотипов атеросклероза НИИ кардиологии им. А.Л. Мясникова
Russian Federation, MoscowAleksei A. Ansheles
National Medical Research Center of Cardiology
Author for correspondence.
Email: a.ansheles@gmail.com
ORCID iD: 0000-0002-2675-3276
д.м.н., ст. науч. сотр. отд. радионуклидной диагностики и ПЭТ НИИ кардиологии им. А.Л. Мясникова
Russian Federation, MoscowSergey A. Boytsov
National Medical Research Center of Cardiology
Email: a.ansheles@gmail.com
ORCID iD: 0000-0001-6998-8406
акад. РАН, д.м.н., проф., ген. дир. ФГБУ «НМИЦ кардиологии»
Russian Federation, MoscowReferences
- Оганов Р.Г., Кухарчук В.В., Арутюнов Г.П., и др. Сохраняющиеся нарушения показателей липидного спектра у пациентов с дислипидемией, получающих статины, в реальной клинической практике в Российской Федерации (российская часть исследования DYSIS). Кардиоваскулярная терапия и профилактика. 2012;4:70-8 [Oganov RG, Kukharchuk VV, Arutyunov GP, et al. Persistent disorders of lipid spectrum parameters in patients with dyslipidemia, receiving statins, in real clinical practice in the Russian Federation (Russian part of the DYSIS study). Cardiovascular therapy and prevention. 2012;4:70-8 (In Russ.)]. doi: 10.15829/1728-8800-2012-4-70-78
- Кухарчук В.В., Ежов М.В., Сергиенко И.В., и др. Диагностика и коррекция нарушений липидного обмена с целью профилактики и лечения атеросклероза. Российские рекомендации. VII пересмотр. Атеросклероз и дислипидемии. 2020;11(1):7-40 [Kukharchuk VV, Ezhov MV, Sergienko IV, et al. Diagnosis and correction of lipid metabolism disorders for the prevention and treatment of atherosclerosis. Russian recommendations. VII revision. Atherosclerosis and dyslipidemia. 2020; 11(1):7-40 (In Russ.)]. doi: 10.34687/2219-8202.JAD.2020.01.0001
- Mach F, Baigent C, Catapano AL, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020;41(1):111-88. doi: 10.1093/eurheartj/ehz455
- Piepoli MF, Hoes AW, Agewall S, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2016;37(29):2315-81. doi: 10.1093/eurheartj/ehw106
